P695 Untargeted proteomics analysis of baseline serum samples prior to biologic therapy initiation
Rauch M, Laponogov I, van Welsen I, Quinn A, Joustra V, Paulich H, Perez B, Ramkisoen R, Noble A, Satsangi J, D’Haens G, Williamson A, Veselkov K, van 't Wout A. P695 Untargeted proteomics analysis of baseline serum samples prior to biologic therapy initiation. Journal Of Crohn's And Colitis 2024, 18: i1316-i1317. DOI: 10.1093/ecco-jcc/jjad212.0825.Peer-Reviewed Original ResearchAnti-TNFa treatmentAnti-TNFaSerum proteomic profilesTreatment outcomesCrohn's diseaseTreatment responseNon-respondersCD patientsBiological drugsModerate to severe CDSerum collectionSustained clinical responseFirst-line therapyBaseline serum samplesProteomic profilingBiobanked serum samplesBiologic treatment outcomesSevere CD patientsSerum samplesBiologic treatment responseStandard of careSerum proteomic analysisClinical responseStratify patientsSevere CD
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply